Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings

被引:45
|
作者
Caselli, Elisabetta [1 ]
机构
[1] Univ Ferrara, Sect Microbiol, CIAS, Dept Med Sci, Via L Borsari 46, I-44121 Ferrara, Italy
来源
MICROBIAL BIOTECHNOLOGY | 2017年 / 10卷 / 05期
关键词
HOSPITAL-ACQUIRED INFECTIONS; ENVIRONMENTAL CONTAMINATION; CLOSTRIDIUM-DIFFICILE; DECONTAMINATION; DISINFECTANTS; TRANSMISSION; PROBIOTICS; SURFACES; PREVENTION; SYSTEMS;
D O I
10.1111/1751-7915.12755
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Healthcare-associated infections (HAIs) are a global concern, affecting all western hospitals, and profoundly impairing the clinical outcome of up to 15% of all hospitalized patients. Persistent microbial contamination of hospital surfaces has been suggested to contribute to HAIs onset, representing a reservoir for hospital pathogens. On the other hand, conventional chemicals-based sanitation do not prevent recontamination and can select drug-resistant strains, resulting in over 50% of surfaces persistently contaminated. There is therefore an urgent need for alternative sustainable and effective ways to control pathogens contamination and transmission. Toward this goal, we recently reported that a probiotic-based sanitation can stably decrease surface pathogens up to 90% more than conventional disinfectants, without selecting resistant species. This paper summarizes some of our most significant results.
引用
收藏
页码:1079 / 1083
页数:5
相关论文
共 50 条
  • [21] UNDERSTANDING AND MANAGING MICROBIAL RESISTANCE IN INSTITUTIONAL SETTINGS
    SCHENTAG, JJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (06) : S9 - S14
  • [22] Strategies to reduce medication errors in pediatric ambulatory settings
    Mehndiratta, S.
    JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (01) : 47 - 53
  • [23] Offer Allergens, reduce or vaccinate Hygiene? Prevention Strategies of the Future
    von Mutius, E.
    ALLERGOLOGIE, 2017, 40 (04) : 164 - 164
  • [24] Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
    Thakur, Aneesh
    Mikkelsen, Heidi
    Jungersen, Gregers
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [25] The Future of Microbial Drug Resistance
    Boneca, Ivo G.
    MICROBIAL DRUG RESISTANCE, 2021, 27 (01) : 1 - 2
  • [26] Targeting metabolic pathways in microbial pathogens:: oxidative stress and anti-folate drug resistance in trypanosomatids
    Hunter, WN
    Alphey, MS
    Bond, CS
    Schüttelkopf, AW
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 607 - 610
  • [27] Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies
    Schwartz, Beth
    Klamer, Katherine
    Zimmerman, Justin
    Kale-Pradhan, Pramodini B.
    Bhargava, Ashish
    PATHOGENS, 2024, 13 (11):
  • [28] A survey of multi-drug resistance clinical pathogens in Turkey - TEST Program, 2006
    Bouchillon, S.
    Badal, R.
    Hackel, M.
    Johnson, J.
    Hoban, D.
    Johnson, B.
    Dowzicky, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S624 - S624
  • [29] Urinary tract infections after renal transplantation - pathogens and drug resistance in clinical practice
    Witzke, O.
    Ross, B.
    Kukalla, J.
    Rath, P. M.
    Steinmann, J.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 : 88 - 88
  • [30] Hospital hygiene. Antibiotic resistance and multidrug Resistant pathogens.
    Kerwat, Klaus
    Kerwat, Martina
    Graf, Juergen
    Wulf, Hinnerk
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2010, 45 (04): : 242 - 243